[HTML][HTML] HIV and Drug Use: A Tale of Synergy in Pulmonary Vascular Disease Development

CM Cook, VD Craddock, AK Ram… - Comprehensive …, 2023 - ncbi.nlm.nih.gov
Over the past two decades, with the advent and adoption of highly active anti-retroviral
therapy, HIV-1 infection, a once fatal and acute illness, has transformed into a chronic …

[HTML][HTML] Clinical outcomes of ventricular assist device support by HIV infection status: an STS-INTERMACS analysis

SE Birk, DA Baran, R Campbell, JM Herre… - The Journal of Heart and …, 2023 - Elsevier
Background Cardiovascular disease remains the leading cause of mortality in human
immunodeficiency virus-infected (HIV-positive) patients. Ventricular assist device therapy is …

Pressure‐based estimation of right ventricular ejection fraction

PM Heerdt, I Singh, A Elassal, V Kheyfets… - ESC Heart …, 2022 - Wiley Online Library
Aims A method for estimating right ventricular ejection fraction (RVEF) from RV pressure
waveforms was recently validated in an experimental model. Currently, cardiac magnetic …

HIV-associated pulmonary arterial hypertension: a report from the pulmonary hypertension association registry

NA Kolaitis, M Lammi, S Mazimba… - American journal of …, 2022 - atsjournals.org
HIV currently infects 38 million people, with 1.7 million diagnoses annually (1). Antiretroviral
therapy extended survival by minimizing acquired immunodeficiency syndrome (2) …

Defining end-systolic pressure for single-beat estimation of right ventricle–pulmonary artery coupling: simple… but not really

I Singh, H Oakland, A Elassal… - ERJ Open Research, 2021 - Eur Respiratory Soc
Functional adaptation of the right ventricle (RV) to its afterload plays an important prognostic
role in pulmonary hypertension (PH)[1]. The preferred “multibeat”(MB) method for assessing …

Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension

VJ Rodriguez-Irizarry, AC Schneider, D Ahle… - Frontiers in …, 2022 - frontiersin.org
People living with HIV and who receive antiretroviral therapy have a significantly improved
lifespan, compared to the early days without therapy. Unfortunately, persisting viral …

Human Immunodeficiency Virus–Associated Pulmonary Arterial Hypertension

NA Kolaitis, CF Barnett - Advances in Pulmonary …, 2022 - meridian.allenpress.com
Human immunodeficiency virus (HIV) attacks the immune system and can cause acquired
immunodeficiency syndrome. Thankfully, antiretroviral therapy is highly effective, and people …